Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Former intel chief says China likely has over 5,000 spies in Taiwan ...

The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Despite significant advances in Parkinson's disease (PD) treatment, it remains incurable, with limited therapeutic options.

In parallel, two cytotoxicity tests were performed using the RTG-2 cell line for assessing the cell viability and mitochondrial activity after exposure to both organic and aqueous EOM extracts. The ...